Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction. (Q39205798)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

D Guasco

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

E Martella

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

M Lazzaretti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

C Mancini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

K Patrene

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Maïga

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

J Anderson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

G David Roodman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

24 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

1697-1706

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23344526%20AND%20SRC:MED&resulttype=core&format=json

The malignant clone and the bone-marrow environment

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Bone marrow angiogenesis in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Advances in the understanding of myeloma bone disease and tumour growth

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Targeting the bone microenvironment in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Do human myeloma cells directly produce basic FGF?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

https://api.crossref.org/works/10.1038%2FLEU.2013.24

1 reference

7 January 2021

The role of hypoxia-inducible factors in tumorigenesis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Hypoxia: a key regulator of angiogenesis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Biology of HIF-1alpha

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Turn me on: regulating HIF transcriptional activity.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

HIF-1 regulation: not so easy come, easy go

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Regulation of cancer cell metabolism by hypoxia-inducible factor 1.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Regulation of angiogenesis by hypoxia-inducible factor 1.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Hypoxia stimulates osteoclast formation from human peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angio

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

MT1-MMP plays a critical role in hematopoiesis by regulating HIF-mediated chemokine/cytokine gene transcription within niche cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021

A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.24

7 January 2021